Since the etiology of dysferlinopathies is genetic, a putative therapeutic solution could be found using gene therapy (providing a normal copy of dysferlin) or gene repair (CRYSPR-Cas9). The gene discussed is DYSF; the disease is neuromuscular disease caused by qualitative or quantitative defects of dysferlin.